Drug Pricing Policies in the United States and Globally image

October 24, 2018 8:00 AM - 5:00 PM
Conferences
2018-2019
Harvard Law School, Wasserstein Hall, Milstein East (2036)
1585 Massachusetts Ave., Cambridge, MA

VIDEO: Welcome remarks, Daniel Aaron, I. Glenn Cohen and Quentin Palfrey
VIDEO: Keynote Address, Ronald Piervincenzi
VIDEO: Panel 1, Sean Dickson, "From Development to Delivery in the United States"
VIDEO: Panel 1, Surya Singh, From Development to Delivery in the United States"
VIDEO: Panel 1, Michael Caljouw, "From Development to Delivery in the United States"
VIDEO: Panel 1, Audience Q & A, "From Development to Delivery in the United States"
VIDEO: Panel 2, Amy Flood, "From Development to Delivery Globally"
VIDEO: Panel 2, Lauren Galinsky, "From Development to Delivery Globally"
VIDEO: Panel 2, Hannah Kettler, "From Development to Delivery Globally"
VIDEO: Panel 2, Audience Q & A, "From Development to Delivery Globally"
VIDEO: Keynote Address, Joe Grogan Lunchtime
VIDEO: Panel 3, Peter B. Bach, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Annette Gaudino, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Jami Taylor, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Audience Q & A, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 4, Muhammad Zaman, "Innovations in Drug Discovery and Policy
VIDEO: Panel 4, Sara Gerke, "Innovations in Drug Discovery and Policy"
VIDEO: Panel 4, Audience Q & A, "Innovations in Drug Discovery and Policy

Description

This one-day conference explored the current pharmaceutical pricing landscape by bringing together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants assessed the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We also explored and articulated best practices to expand access to medicines and worked toward developing a plan for disseminating these practices more widely.

This event was free and open to the public.

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society, with support from Gilead Sciences, Inc.

Agenda

8:00 - 8:30am, Registration

8:30 - 8:45am, Welcome Remarks

  • Daniel Aaron, JD/MD Candidate, Class of 2020, Harvard Law School and Boston University School of Medicine

  • I. Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

8:45 - 9:30am, Keynote Address

9:30 - 10:45am, Panel I: From Development to Delivery in the United States

  • Michael Caljouw, Vice President, State Government and Regulatory Affairs, Blue Cross Blue Shield of Massachusetts

  • Sean Dickson, Officer, Drug Spending Research Initiative, The Pew Charitable Trusts

  • Surya Singh, Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health

  • Moderator: Carmel Shachar, Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and Lecturer at Law, Harvard Law School

10:45 - 11:00am, Break

11:00am - 12:15pm, Panel II: From Development to Delivery Globally

  • Amy Flood, Senior Vice President, Public Affairs, Gilead Sciences, Inc.

  • Lauren Galinsky, Senior Clinical Operations Strategy Advisor, Partners in Health

  • Hannah Kettler, Senior Program Officer, Industry Leadership Engagement and Thinkubator Lead, Bill & Melinda Gates Foundation

  • Moderator: Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

12:15 - 12:45pm, Keynote Address

  • Joe GroganAssociate Director, Health Programs, Office of Management and Budget

12:45 - 1:45pm, Networking Lunch

1:45 - 3:00pm, Panel III: Best Practices in Pricing Policy for Essential Drugs

  • Peter B. BachDirector, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

  • Annette Gaudino, ​HIV/HCV Project Co-Director, Treatment Action Group (TAG)

  • Aaron S. Kesselheim, Director, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham & Women’s Hospital, and Associate Professor of Medicine, Harvard Medical School

  • Jami Taylor, Managing Director, Stanton Park Capital

  • Moderator: William W. FisherWilmerHale Professor of Intellectual Property Law, Harvard Law School, and Faculty Director, Berkman Klein Center for Internet and Society at Harvard University

3:00 - 3:15pm, Break

3:15 - 4:30pm, Panel IV: Innovations in Drug Discovery and Policy

  • Sara Gerke, Research Fellow in Precision Medicine, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Muhammad Zaman, Professor, Biomedical Engineering, Boston University

  • Moderator: Ashveena Gajeelee, Research Fellow, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society, with support from Gilead Sciences, Inc.

 

Learn more

Slide Presentations

Videos

VIDEO: Welcome remarks, Daniel Aaron, I. Glenn Cohen and Quentin Palfrey
VIDEO: Keynote Address, Ronald Piervincenzi
VIDEO: Panel 1, Sean Dickson, "From Development to Delivery in the United States"
VIDEO: Panel 1, Surya Singh, From Development to Delivery in the United States"
VIDEO: Panel 1, Michael Caljouw, "From Development to Delivery in the United States"
VIDEO: Panel 1, Audience Q & A, "From Development to Delivery in the United States"
VIDEO: Panel 2, Amy Flood, "From Development to Delivery Globally"
VIDEO: Panel 2, Lauren Galinsky, "From Development to Delivery Globally"
VIDEO: Panel 2, Hannah Kettler, "From Development to Delivery Globally"
VIDEO: Panel 2, Audience Q & A, "From Development to Delivery Globally"
VIDEO: Keynote Address, Joe Grogan Lunchtime
VIDEO: Panel 3, Peter B. Bach, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Annette Gaudino, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Jami Taylor, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 3, Audience Q & A, "Best Practices in Pricing Policy for Essential Drugs"
VIDEO: Panel 4, Muhammad Zaman, "Innovations in Drug Discovery and Policy
VIDEO: Panel 4, Sara Gerke, "Innovations in Drug Discovery and Policy"
VIDEO: Panel 4, Audience Q & A, "Innovations in Drug Discovery and Policy

Tags

biotechnology   fda   global health   health care costs   health care finance   health law policy   innovation   international   pharmaceuticals   public health   regulation   research   research funding